Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities.
Andrea Vanzulli, Raffaella Vigorito, Ciriaco Buonomenna, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Robert Díaz Beveridge, Virginia Ferraresi, Iwona Ługowska, Sara Pizzamiglio, Paolo Verderio, Valeria Duroni, Valeria Fontana, Carlo Morosi, Silvia Stacchiotti, Alessandro Gronchi (2024). Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities.. , 42(16_suppl), DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.11553.
